Doximity, Inc.(DOCS)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
DOCS | 3.45 B | 32.26x | 7.30% | 25.48% | $0.84 | 17.21% | 1.06 | - | $76.51 | $17.15 |
VEEV | 46.04 B | 46.70x | 17.60% | 29.35% | $6.09 | 14.43% | 2.04 | - | $310.50 | $148.05 |
WAY | 5.00 B | 37.26x | 18.10% | 11.18% | $0.70 | 3.77% | 0.37 | - | $41.47 | $17.26 |
HTFL | 4.32 B | -14.93x | 47.60% | -55.82% | $-3.33 | -1.54% | 9.70 | - | $51.19 | $20.13 |
SDGR | 1.36 B | -28.37x | 7.50% | -20.98% | $-0.73 | -16.17% | 0.33 | - | $23.02 | $10.94 |
Peer Valuation & Performance Analysis
Peer group analysis for Doximity, Inc. (DOCS) compared to its primary competitors (including VEEV, WAY, HTFL) reveals distinct metrics. DOCS trades at a valuation premium compared to its competitors, with a P/E ratio of 32.3x versus the peer average of 10.2x (representing a 217% premium). This indicates that the market expects superior growth or commands a quality premium for DOCS. In terms of growth, DOCS's revenue growth of 7.3% lags behind the peer average of 22.7%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 25.5% compared to the peer average of -9.1%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• DOCS ranks #1 in P/E ratio, #5 in revenue growth, and #2 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $26.70 | $27.32 | $26.50 | $27.10 | 2,524,200 | +1.50% |
| 2026-09-02 | $26.26 | $27.00 | $26.20 | $26.32 | 1,977,600 | +0.23% |
| 2026-09-01 | $26.33 | $27.03 | $26.21 | $26.35 | 2,029,400 | +0.08% |
| 2026-08-31 | $25.84 | $26.85 | $25.84 | $26.71 | 2,194,200 | +3.37% |
| 2026-08-28 | $25.61 | $26.87 | $25.33 | $26.73 | 3,288,600 | +4.37% |
| 2026-08-27 | $25.13 | $25.81 | $24.89 | $25.59 | 2,466,500 | +1.83% |
| 2026-08-26 | $24.50 | $25.20 | $24.48 | $24.74 | 1,888,800 | +0.98% |
| 2026-08-25 | $24.95 | $25.35 | $24.60 | $24.74 | 1,725,400 | -0.84% |
| 2026-08-24 | $25.34 | $26.08 | $25.10 | $25.30 | 2,869,400 | -0.16% |
| 2026-08-21 | $25.84 | $25.87 | $25.12 | $25.33 | 2,676,600 | -1.97% |
| 2026-08-20 | $25.63 | $26.46 | $25.18 | $25.94 | 2,562,700 | +1.21% |
| 2026-08-19 | $24.95 | $25.91 | $24.81 | $25.75 | 4,900,800 | +3.21% |
| 2026-08-18 | $24.94 | $25.28 | $24.75 | $24.94 | 2,978,300 | - |
| 2026-08-17 | $24.41 | $24.64 | $23.95 | $24.52 | 3,453,300 | +0.45% |
| 2026-08-14 | $26.61 | $26.70 | $24.80 | $24.80 | 4,115,600 | -6.82% |
Explore More Analysis for DOCS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.